SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Cantor Fitzgerald Maintains Neutral on Puma Biotechnology, Raises Price Target to $16

Cantor Fitzgerald maintains Puma Biotechnology (NASDAQ:PBYI) with a Neutral and raises the price target from $14 to $16.

Benzinga · 05/20/2020 11:24

Cantor Fitzgerald maintains Puma Biotechnology (NASDAQ:PBYI) with a Neutral and raises the price target from $14 to $16.